Cutaneous melanoma, version 2.2019

Daniel G. Coit, John A. Thompson, Mark R. Albertini, Christopher Barker, William E. Carson, Carlo Contreras, Gregory A. Daniels, Dominick DiMaio, Ryan C. Fields, Martin D. Fleming, Morganna Freeman, Anjela Galan, Brian Gastman, Valerie Guild, Douglas Johnson, Richard W. Joseph, Julie R. Lange, Sameer Nath, Anthony J. Olszanski, Patrick OttAparna Priyanath Gupta, Merrick I. Ross, April K. Salama, Joseph Skitzki, Jeffrey Sosman, Susan M. Swetter, Kenneth K. Tanabe, Evan Wuthrick, Nicole R. McMillian, Anita M. Engh

Research output: Contribution to journalReview article

45 Scopus citations

Abstract

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cutaneous melanoma have been significantly revised over the past few years in response to emerging data on immune checkpoint inhibitor therapies and BRAF-targeted therapy. This article summarizes the data and rationale supporting extensive changes to the recommendations for systemic therapy as adjuvant treatment of resected disease and as treatment of unresectable or distant metastatic disease.

Original languageEnglish (US)
Pages (from-to)367-402
Number of pages36
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume17
Issue number4
DOIs
StatePublished - Apr 2019

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Cutaneous melanoma, version 2.2019'. Together they form a unique fingerprint.

  • Cite this

    Coit, D. G., Thompson, J. A., Albertini, M. R., Barker, C., Carson, W. E., Contreras, C., Daniels, G. A., DiMaio, D., Fields, R. C., Fleming, M. D., Freeman, M., Galan, A., Gastman, B., Guild, V., Johnson, D., Joseph, R. W., Lange, J. R., Nath, S., Olszanski, A. J., ... Engh, A. M. (2019). Cutaneous melanoma, version 2.2019. JNCCN Journal of the National Comprehensive Cancer Network, 17(4), 367-402. https://doi.org/10.6004/jnccn.2019.0018